Balaji Amines Limited (530999) Earnings Call Transcripts

Balaji Amines Limited's Latest Earnings Call - Q4 FY2026

In Q4 FY '26, Balaji Amines Limited reported total revenue of INR 403 crore, a 12% increase year-on-year from INR 361 crore in Q4 FY '25. The company's profit after tax rose to INR 65 crore, up from INR 40 crore in the same quarter last year, reflecting strong operational performance despite external challenges. Management maintained a positive outlook for FY '27, projecting a 25% to 30% volume growth driven by new product launches and improved capacity utilization, while EBITDA margins are expected to remain sustainable between 22% to 23%.

Reported metrics

Guidance from management

Management expects a volume growth of 25% to 30% in FY '27, with EBITDA margins projected to remain sustainable between 22% to 23%. They noted that the commissioning of new plants will be crucial for achieving these targets.

What management said

See, it is for you, you are feeling it is a large manufacturer. But for us, what we have seen is their requirement of the dimethylformamide maybe about 15% to 20% of the total -- our outflow. And secondly, even today also, they are buying even this month also, they are buying from us. I don't know where from you got and maybe they have some problems or maybe our cost is later than their cost of production, even today...

Part of the specialty chemicals be -- the subsidiary is not working in full position because of the activities for the modification. It is working 10 days, working and 15 days is working for this modifications, repairs are going on, which goes into the expenses, which going for the modification definitely goes into the capitalization.

What analysts pressed on

Analysts expressed concerns regarding the low capacity utilization rates and the impact of raw material price volatility on margins. There were questions about the rationale behind further expansions despite current underutilization levels, and potential risks associated with key customer dependencies.

Main topics on the call

• Revenue Growth — Balaji Amines reported a consolidated revenue of INR 1,454 crore for FY '26, slightly up from INR 1,430 crore in FY '25, indicating steady growth despite external challenges. Management stated, 'the performance during th...
• Improved Profitability — The company's EBITDA for Q4 FY '26 was INR 102 crore, up from INR 68 crore in Q4 FY '25, with an EBITDA margin improving to 25%. This improvement was attributed to 'better operating leverage, stable raw material conditio...
• Volume Growth Guidance — Management guided for a volume growth of 25% to 30% in FY '27, driven by new products like dimethyl ether and acetonitrile. They stated, 'the commissioning of DME, NMM, ACN... will be important milestones over the coming...
• Debt Management — Balaji Amines continues to operate as a zero-debt company, reflecting strong financial discipline. Management emphasized, 'our consolidated balance sheet continues to remain strong,' which supports future growth initiati...

Read the full Balaji Amines Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 18 Balaji Amines Limited earnings call transcripts on record, spanning February 3, 2020 to May 18, 2026. Based on this history, Balaji Amines Limited reports semi-annually. The most recent call on file is dated May 18, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

530999

Exchange

BSE

Country

IN

Sector

Materials

Industry

Chemicals

Calls on record

18

First call

February 3, 2020

Most recent

May 18, 2026

Reporting cadence

semi-annually